858 Therapeutics Stock

858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology.

Sign up today and learn more about 858 Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Invest Now Sell Shares

About 858 Therapeutics Stock

858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology. The company was founded in 2019 and is headquartered in San Diego, California, USA.

Funding History

March 2020	$20.1M
September 2021	$60.0M

Management

CEO and Founder

Jeffrey Stafford

Board Member

Ali Behbahani

Chief Scientific Officer

Jim Veal

Board Member

Clare Ozawa

VP of Biology

Gretchen Bain

Press

linkedin - Apr, 6 2024

858 Therapeutics on LinkedIn: 858 Therapeutics to Present Preclinical Data on ETX-19477 at the AACR 2024…

businesswire - Apr, 6 2024

858 Therapeutics to Present Preclinical Data on ETX-19477 at the AACR 2024 Annual Meeting

bioworld - Dec, 20 2023

858 Therapeutics patents new PARG inhibitors for cancer

biospace - Apr, 5 2022

858 Therapeutics Expands Board of Directors and Leadership Team

dlvr - Sep, 30 2021

After their startups were acquired, 3 biotech executives try a second act with San Diego’s 858 Therapeutics

Trending Companies

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Join Now

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen Inc. was awarded a 2023 Fintech Breakthrough Award by Tech Breakthrough LLC on or about March 23, 2023, based on the prior calendar year and covering calendar year 2023, and has compensated Tech Breakthrough LLC for use of its name and logo in connection with the award. Tech Breakthrough LLC is a third party and has no affiliation with EquityZen.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2024 EquityZen Inc. All rights reserved.